Acarix A/S (ACARIX) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.442x

Based on the latest financial reports, Acarix A/S (ACARIX) has a cash flow conversion efficiency ratio of -0.442x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-16.89 Million ≈ $-1.82 Million USD) by net assets (Skr38.17 Million ≈ $4.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Acarix A/S - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Acarix A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Acarix A/S (ACARIX) total liabilities for a breakdown of total debt and financial obligations.

Acarix A/S Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Acarix A/S ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Inbest Prime IV Inmuebles SOCIMI S.A. MC:YINB4	N/A
POLARIS WORKS Inc KQ:123010	0.019x
Gol Linhas Aéreas Inteligentes S.A NYSE:GOLLQ	-0.024x
Cipherlab Co Ltd TWO:6160	-0.109x
Gabriel Resources Ltd V:GBU	0.080x
Mendus AB (publ) ST:IMMU	-0.139x
Sterling Metals Corp V:SAG	-0.027x
Subur Tiasa Holdings Bhd KLSE:6904	0.094x

Annual Cash Flow Conversion Efficiency for Acarix A/S (2014–2025)

The table below shows the annual cash flow conversion efficiency of Acarix A/S from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see ACARIX market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr38.17 Million ≈ $4.11 Million	Skr-48.38 Million ≈ $-5.21 Million	-1.268x	-51.52%
2024-12-31	Skr75.70 Million ≈ $8.15 Million	Skr-63.33 Million ≈ $-6.81 Million	-0.837x	+46.65%
2023-12-31	Skr51.88 Million ≈ $5.58 Million	Skr-81.37 Million ≈ $-8.76 Million	-1.568x	-8.55%
2022-12-31	Skr51.83 Million ≈ $5.58 Million	Skr-74.87 Million ≈ $-8.06 Million	-1.445x	-202.56%
2021-12-31	Skr100.54 Million ≈ $10.82 Million	Skr-48.01 Million ≈ $-5.17 Million	-0.477x	-6.90%
2020-12-31	Skr82.14 Million ≈ $8.84 Million	Skr-36.69 Million ≈ $-3.95 Million	-0.447x	+23.17%
2019-12-31	Skr76.60 Million ≈ $8.24 Million	Skr-44.53 Million ≈ $-4.79 Million	-0.581x	-32.32%
2018-12-31	Skr87.88 Million ≈ $9.46 Million	Skr-38.61 Million ≈ $-4.15 Million	-0.439x	-39.74%
2017-12-31	Skr128.94 Million ≈ $13.88 Million	Skr-40.54 Million ≈ $-4.36 Million	-0.314x	-439.92%
2016-12-31	Skr155.52 Million ≈ $16.74 Million	Skr-9.06 Million ≈ $-974.57K	-0.058x	+91.81%
2015-12-31	Skr12.14 Million ≈ $1.31 Million	Skr-8.63 Million ≈ $-928.83K	-0.711x	+48.48%
2014-12-31	Skr15.12 Million ≈ $1.63 Million	Skr-20.87 Million ≈ $-2.25 Million	-1.380x	--

About Acarix A/S

ST:ACARIX Sweden Medical Devices

Market Cap

$33.84 Million

Skr314.47 Million SEK

Market Cap Rank

#23303 Global

#445 in Sweden

Share Price

Skr0.27

Change (1 day)

-2.88%

52-Week Range

Skr0.20 - Skr0.43

All Time High

Skr20.62